Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
ELANTAS Beck India Limited

ELANTAS Beck India Limited

NSE: ELANTAS
Specialty ChemicalsBasic MaterialsMID CAPMCap ₹11.13k Cr
₹14,036.00₹244.00 (+1.77%)

Market Closed • NSE

Market cap₹11.13k Cr
Enterprise value₹10.22k Cr
P/E TTM62.66
P/B10.08
EPS TTM₹224.00
ROE0.17%
ROA0.11%
Dividend yield0.00%
52W high₹15,150.00
52W low₹8,900.00
Price chart(1Y)
1Y Return:+47.05% (+₹4491.00)
H: ₹15,150L: ₹9,016.5
1W+1.01%
1M+2.56%
3M+47.05%
6M+52.19%
Today at a glance

Day range

₹13,802.00₹14,104.00

52 week range

₹8,900.00₹15,150.00
Volume9640.38x 20D avg
Free float50.00%-62.00% volume

ELANTAS Beck India Limited closed at INR14036.00 (+1.77%) on volume 0.38x its 20-day average, trading 7.35% below its 52-week high.

Technical analysis
RSI (14)57.0Neutral (30–70)
MACDBEARISHBearish (Below signal)
ATR (14)₹566.58High
SMA 20₹13,918.60BULLISH
SMA 50₹12,954.22BULLISH
SMA 100₹11,423.68BULLISH
SMA 200—N/A
CPR bottom₹13,869.50
Pivot₹13,843.67
CPR top₹13,817.83
What changed recently?

2026-Q1

Q1 FY2026 Financial Results

PAT moved -21% QoQ

2026-05-05

DIVIDEND Announced

Dividend - Rs. 7.50 Per Share

Shariah audit
Methodology: AAOIFI Shariah Standard No. 21
PENDING_DATA3/4 criteria
Pending Data
CriteriaNumeratorDenominatorValueThresholdStatus
Interest-bearing debt ratio–₹11.13k Cr—≤ 33%PENDING_DATA
Non-halal income ratio₹4.0 Cr₹845.9 Cr0.47%≤ 5%PASS
Illiquid assets ratio₹1.10k Cr₹1.17k Cr94.34%≥ 20%PASS
Receivables ratio–₹1.17k Cr—≤ 49%PASS
Valuation & sector context
MetricCompanySector
P/E62.6621.90
Forward P/E——
P/B10.082.20
EV/EBITDA—18.00
PEG—1.00
Earnings yield1.604.60
Growth & profitability
RevenuePAT
FY17PAT margin —
FY18PAT margin —
FY19PAT margin —
FY23PAT margin 20.30%
FY24PAT margin 18.70%
FY25PAT margin 17.50%

Revenue and PAT bars use independent scales to make their year-on-year direction readable.

Revenue CAGR 3Y+29.00%
Revenue CAGR 5Y+16.70%
PAT CAGR 3Y—
PAT CAGR 5Y—
Operating margin26.72%
Net margin18.80%
Financial health & cash flow
Net debt–Moderate
Interest coverage294.40xEBIT / interest
CFO / PAT0.76x3Y average
Net debt / EBITDA—Leverage
Operating cash flow₹127.1 Cr
Capital expenditure–
Free cash flow₹96.2 Cr
Financial statements

Complete reported financial history · Values use the company's reporting currency

Hover over the chart for exact reported values. Percentage lines use the right-hand axis.

Fundamental scorecard
Overall50/100
Valuation35/100
Profitability50/100
Financial health65/100

A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.

Strengths, risks & investment thesis

Strengths

Established operational history in the sector

Active institutional participation

Risks

Stretched Valuation: Trading at a high P/E multiple of 62.7x

Bull case

Market Leadership: Established operational scale in Specialty Chemicals.

Bear case

Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.

Flip condition

Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.

Shareholding pattern
Quarterly ownership historyLatest valid period · December 2025

Ownership distribution

Dec 2025Latest holding

Category trends

Hover over a period for exact holdings

80%53%27%0%Sept 2024Dec 2024Jun 2025Sept 2025Dec 2025
12.29%Institutional holding
12.71%Public holding
5Periods available
0.00%Promoter pledged
9.31KShareholders
Corporate Action

Complete dividend, bonus, split, rights and other action history

Record dateCorporate actionInformationAnnouncement dateEx-date
05 May 2026Dividend₹7.50 / share—05 May 2026
Delivery participation

Traded volume and delivery percentage across the latest 20 sessions

Average delivery (20D)46.65%+1.48% latest vs average
Highest delivery69.95%on 14 Oct
Average volume (20D)2.5KTrading-session average
Conviction trendStrengthening+1.48% latest reading
Traded volumeDelivery %
Peer comparison

Compare valuation, latest quarterly performance and year-on-year growth

8 companies
Company nameMarket cap ₹ CrP/E ratioDividend yield %Quarterly sales ₹ CrProfit after tax ₹ CrSales growth %Profit growth %
UltraTech Cement Limited
UltraTech Cement LimitedULTRACEMCO
Open analysis
₹3.21L37.592.21%₹25,799.47₹2,982.76+11.86%+20.17%
JSW Steel Limited
JSW Steel LimitedJSWSTEEL
Open analysis
₹2.97L12.050.59%₹47,364.00₹4,651.00+11.55%+112.96%
Hindustan Zinc Limited
Hindustan Zinc LimitedHINDZINC
Open analysis
₹2.28L13.372.07%₹13,687.00₹5,425.00+77.22%+146.14%
Asian Paints Limited
Asian Paints LimitedASIANPAINT
Open analysis
₹2.24L46.941.17%₹10,541.94₹1,539.25+17.94%+39.96%
Tata Steel Limited
Tata Steel LimitedTATASTEEL
Open analysis
₹2.19L19.832.27%₹60,794.00₹2,385.00+14.32%+18.83%
Hindalco Industries Limited
Hindalco Industries LimitedHINDALCO
Open analysis
₹2.02L12.320.56%₹84,825.00₹7,013.00+32.06%+75.15%
Grasim Industries Limited
Grasim Industries LimitedGRASIM
Open analysis
₹1.98L34.820.35%₹11,794.71₹246.65-70.60%-82.61%
Solar Industries India Limited
Solar Industries India LimitedSOLARINDS
Open analysis
₹1.81L90.930.06%₹3,668.00₹666.00+70.29%+88.67%
About ELANTAS Beck India Limited
ELANTAS Beck India Limited

Elantas Beck India Ltd (EBIL) manufactures specialty insulation and protective materials: wire enamels, varnishes/resins, casting/potting compounds, PCB-protection systems and engineering/construction materials. It has plants at Pimpri and Ankleshwar and is 75%-owned by Germany's ELANTAS GmbH.[1]

IndiaBasic Materials

Questions investors ask
Is ELANTAS Beck India Limited Shariah compliant?

ELANTAS Beck India Limited is currently screened as Pending Data under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Interest-bearing debt or Market Cap data unavailable for ratio screening. Financial ratio screening incomplete due to missing balance sheet or market cap data.

What is ELANTAS Beck India Limited's current valuation relative to peers?

ELANTAS Beck India Limited trades at a P/E of 62.7x compared to the sector median of 21.9x, and a Price-to-Book of 10.1x.

Is the company financially healthy?

The company has a Debt-to-Equity ratio of zero debt. Interest coverage is 294.4x.

What are the historical revenue and profit growth rates?

Over the past 5 years, revenue compounded at 16.7% while net profit growth averaged consistent levels.

Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.

Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.